Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
Authors
Keywords
Neuromyelitis optica, Rituximab, Meta-analysis, Aquaporin-4 autoantibody, Annualized relapse rate, Expanded disability status scale
Journal
BMC Neurology
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-03-06
DOI
10.1186/s12883-019-1261-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Rituximab antibody in patients with NMOSDs treated with low dose Rituximab
- (2018) Ting Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
- (2018) E. C. Tallantyre et al. JOURNAL OF NEUROLOGY
- Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study
- (2018) Philippe Cabre et al. JOURNAL OF NEUROLOGY
- Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and lower dosages of rituximab among patients with neuromyelitis optica spectrum disorder
- (2018) Yang Yang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
- (2017) Zahra Nikoo et al. JOURNAL OF NEUROLOGY
- Monitoring CD27 + memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study
- (2017) M. Cohen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up
- (2017) M.E. Evangelopoulos et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Monoclonal antibody therapy for neuromyelitis optica spectrum disorder: current and future
- (2016) Jie Lin et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study
- (2016) Pietro Annovazzi et al. JOURNAL OF NEUROLOGY
- Atmospheric Plasma Spraying of Single Phase Lanthanum Zirconate Thermal Barrier Coatings with Optimized Porosity
- (2016) Georg Mauer et al. Coatings
- Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
- (2015) Hélène Zéphir et al. JOURNAL OF NEUROLOGY
- Efficacy of rituximab in refractory neuromyelitis optica
- (2015) N Collongues et al. Multiple Sclerosis Journal
- Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints
- (2015) In Hye Jeong et al. Multiple Sclerosis Journal
- Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder
- (2015) Giorgia Olivieri et al. NEUROLOGICAL SCIENCES
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica
- (2015) Su-Hyun Kim et al. JAMA Neurology
- Efficacy of rituximab in refractory neuromyelitis optica
- (2015) N Collongues et al. Multiple Sclerosis Journal
- Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints
- (2015) In Hye Jeong et al. Multiple Sclerosis Journal
- Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment
- (2014) Kelley Weinfurtner et al. JOURNAL OF CHILD NEUROLOGY
- Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
- (2014) R. C. Dale et al. NEUROLOGY
- Experience with low-dose rituximab in off-label indications at two tertiary hospitals
- (2013) J. Chay et al. INTERNAL MEDICINE JOURNAL
- Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases
- (2013) Viktoria Gredler et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica
- (2013) C.-S. Yang et al. NEUROLOGY
- Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
- (2013) Ilya Ayzenberg et al. JAMA Neurology
- Molecular Pathogenesis of Neuromyelitis Optica
- (2012) Wajih Bukhari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Variable results after rituximab in neuromyelitis optica
- (2012) J.W. Lindsey et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders
- (2012) Vincent H.L. Ip et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
- (2011) Su-Hyun Kim ARCHIVES OF NEUROLOGY
- Impact of rituximab on relapse rate and disability in neuromyelitis optica
- (2011) Gurdesh S Bedi et al. Multiple Sclerosis Journal
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
- (2011) H. L. Pellkofer et al. NEUROLOGY
- Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
- (2009) Anu Jacob et al. ARCHIVES OF NEUROLOGY
- Treatment of Neuromyelitis Optica With Rituximab
- (2008) ARCHIVES OF NEUROLOGY
- Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
- (2008) S. Jarius et al. BRAIN
- Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus
- (2008) Julius Birnbaum et al. Nature clinical practice. Rheumatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started